action of glp 1 agonist GLP-1 receptor agonists for individualized treatment type 2 diabetes mellitus Frontiers | Exploring the multifaceted

We note that the new and revised CPT codes are assigned to comment indicator NP in Addendum B to the proposed rule to indicate that the code is new for the next calendar year or the code is an existing code with substantial revision to its code descriptor in the next calendar year as compared to the current calendar year with a proposed APC assignment, and that comments would be accepted on the proposed APC assignment and status indicator

At week 12, there were no significant differences found between the treatment and placebo groups in terms of the total number of UV spots, spot polarization, or measurements of skin tone

In general, without knowing what Medicaid and Medicare generally are currently paying for these drugs on net, it is uncertain whether the lower prices that will be made available to state Medicaid programs and Part D plans under the BALANCE Model for currently covered uses of GLP-1s will generate enough savings to offset the additional costs from expanded use of these medications for obesity

+2 Thanks Sam

Adamo, M

Lipid Res 2013, 54 (10), 27752784